Drug Shortage Report for MAXIDEX

Last updated on 2020-02-27 History
Report ID 97281
Drug Identification Number 00042560
Brand name MAXIDEX
Common or Proper name MAXIDEX 0.1% SUSP 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE
Strength(s) 0.1%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-10-23
Estimated end date 2020-02-28
Actual end date 2020-02-26
Shortage status Resolved
Updated date 2020-02-27
Company comments Supply interruption
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-02-27 English Compare
v16 2020-02-26 French Compare
v15 2020-02-26 English Compare
v14 2020-02-24 French Compare
v13 2020-02-24 English Compare
v12 2019-12-16 French Compare
v11 2019-12-16 English Compare
v10 2019-12-16 French Compare
v9 2019-12-16 English Compare
v8 2019-12-02 French Compare
v7 2019-12-02 English Compare
v6 2019-10-25 French Compare
v5 2019-10-25 English Compare
v4 2019-10-25 French Compare
v3 2019-10-25 French Compare
v2 2019-10-25 English Compare
v1 2019-10-25 English Compare

Showing 1 to 17 of 17